Editas gives first look at CRISPR data in sickle cell, beta thalassemia six months after layoffs, refocus
At the start of this year, Editas Medicine narrowed its pipeline and laid off 20% of its workforce, a move to save cash and focus
At the start of this year, Editas Medicine narrowed its pipeline and laid off 20% of its workforce, a move to save cash and focus
Nearly 11 years ago, scientists programmed a pair of molecular scissors to make precise cuts in DNA. That first test tube experiment of CRISPR gene
→ There’s a shakeup at the top of Chemomab Therapeutics as the Israeli biotech halts the start of a Phase II study to save cash.
PHOENIX — Newer MitraClip devices reduced mitral regurgitation (MR) to no more than a trace for nearly all patients, regardless of anatomical complexity or presence
Doctors have been raising questions about a video on social media of a physician allegedly injecting stem cells into the carotid artery of a fully
In a post-hoc analysis of the ADVANCE and MOTIVATE phase III induction studies, along with the FORTIFY maintenance study, researchers evaluated the safety profile of
At the American Society of Clinical Oncology (ASCO) annual meeting, a presentation titled “Are We Splitting the HERs? The Highs and the Lows” examined three
Small physiological changes can result from wearing an N95 mask all day, including during light exercise, a small trial found. Whether this has practical implications
Note that some links may require subscriptions. Another two deaths tied to a Seattle hospital’s Klebsiella pneumoniae outbreak were confirmed, bringing the total death count
Congress must act to rein in consolidation in the healthcare system while still encouraging competition, Shawn Martin of the American Academy of Family Physicians (AAFP)